AzTrials
AzTrials

Acute Myocardial InfarctionCAMIRegistryNCT01874691

China Acute Myocardial Infarction Registry

An observational study of Acute Myocardial Infarction, run by Chinese Academy of Medical Sciences, Fuwai Hospital at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is to build a Chinese national registry and surveillance system for acute myocardial infarction(AMI) to obtain real-world information about current status of characteristics, risk factors, diagnosis, treatment and outcomes of Chinese AMI patients; And to propose scientific precaution strategies aimed to… Read more about this study

Who is it for?
Any age
Conditions the study is for
Acute Myocardial Infarction
How many people
20,000 participants
Where
1 siteChina
Study dates
Jan 2013to Dec 2016
How long will I take part?
2 Years
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Eligible patients admitted within 7 days of acute ischemic symptoms and diagnosed acute ST-elevation or non ST-elevation myocardial infarction.

Who may be able to join

  • Eligible patients must be admitted within 7 days of acute ischemic symptoms and diagnosed acute ST-elevation or non ST-elevation myocardial infarction. Diagnosis criteria must meet Universal Definition for AMI (2012). All participating hospitals are required to enroll consecutive patients with AMI.

Who cannot join

  • Myocardial infarction related to percutaneous coronary intervention and coronary artery bypass grafting.

Trial locations and contacts

1 site in 1 country.

China1 site

  • Fuwai Hospital

    Beijing, Beijing Municipality, 100037

Other trials in China

About this study

This study is to build a Chinese national registry and surveillance system for acute myocardial infarction(AMI) to obtain real-world information about current status of characteristics, risk factors, diagnosis, treatment and outcomes of Chinese AMI patients; And to propose scientific precaution strategies aimed to prevent effectively from the incidence of AMI; And to optimize the management and outcomes of AMI patients through implementation of guideline recommendations in clinical practice, and analysis and development of effective treatment strategies; And to create cost-effective assessment system.

Read the detailed description

The aim of the study is to establish the national platform for surveillance, clinical research and translational medicine in China, designed to facilitate efforts to improve the quality of AMI patient care and thus decrease morbidity and mortality associated with AMI.

Keywords
acute myocardial infarction, China, Registry

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01874691
Study groupRoleWhat they receive
acute myocardial infarctionacute myocardial infarction including ST-elevation and non ST-elevation myocardial infarction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. In-hospital mortality of the patients with acute myocardial infarction in different-level hospitals across China

    Different-level hospitals include Provincial-level, city-level, County-level hospitals from all over China.

    Measured: the duration of hospital stay, an expected average of 2 weeks

Secondary outcomes (2)

  1. The rate of the application of thrombolysis and primary percutaneous coronary intervention for Chinese patients with acute myocardial infarction in different-level hospitals

    In different-level hospitals, How many patients with acute myocardial infarction receive thrombolysis and/or primary percutaneous coronary intervention within 24 hours from the onset,respectively?

    Measured: 24 hours

  2. provoking factors of Chinese patients with AMI across different areas and different population in China

    The different factors that can provoke the onset of acute myocardial infarction, for example, excess exercise, overload work, heavy smoking, heavy drinking of alcohol and so on.

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jun 2013 (estimated)
  2. Study startJan 2013
  3. Primary completionDec 2016
  4. Study completionDec 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
20,000 participants (actual)
Target duration
2 Years
IDs, dates and publications
ClinicalTrials.gov ID
NCT01874691
Sponsor's protocol ID
2011BAI11B02-A
Other IDs
2011BAI11B02
Acronym
CAMIRegistry
Status last verified
May 2022
First submitted
4 Jun 2013
Last updated
12 May 2022
Results posted
No
Data monitoring committee
Yes

Publications

  • Peterson ED, Roe MT, Rumsfeld JS, Shaw RE, Brindis RG, Fonarow GC, Cannon CP. A call to ACTION (acute coronary treatment and intervention outcomes network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):491-9. doi: 10.1161/CIRCOUTCOMES.108.847145.

    PubMed 20031882

  • Song Z, Danzeng C, Jiang Y, Yang J, Yang W, Qian H, Yang Y. Association Between Admission Blood Pressure and In-hospital Mortality and Long-term Mortality of Patients With ST-elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A China Acute Myocardial Infarction Registry Study. Rev Cardiovasc Med. 2025 Aug 30;26(8):33512. doi: 10.31083/RCM33512. eCollection 2025 Aug.

    PubMed 40927077

  • Wu C, Zhang Z, Su S, Xu H, Song L, Wu Y, Qiao S, Wang Y, Li W, Tang Y, Gao X, Yang J, Yang Y; China Acute Myocardial Infarction Registry Study Group. Role of heavy sweating for ST-segment elevation myocardial infarction: analysis of the China Acute Myocardial Infarction registry. BMC Cardiovasc Disord. 2025 May 20;25(1):385. doi: 10.1186/s12872-025-04840-3.

    PubMed 40394465

  • Yang J, Li Y, Li X, Tao S, Zhang Y, Chen T, Xie G, Xu H, Gao X, Yang Y. A Machine Learning Model for Predicting In-Hospital Mortality in Chinese Patients With ST-Segment Elevation Myocardial Infarction: Findings From the China Myocardial Infarction Registry. J Med Internet Res. 2024 Jul 30;26:e50067. doi: 10.2196/50067.

    PubMed 39079111

  • Xu X, Wang Z, Yang J, Fan X, Yang Y. Burden of cardiac arrhythmias in patients with acute myocardial infarction and their impact on hospitalization outcomes: insights from China acute myocardial infarction (CAMI) registry. BMC Cardiovasc Disord. 2024 Apr 23;24(1):218. doi: 10.1186/s12872-024-03889-w.

    PubMed 38654151

  • Yang J, Zhao Y, Wang J, Ma L, Xu H, Leng W, Wang Y, Wang Y, Wang Z, Gao X, Yang Y; China Acute Myocardial Infarction Registry Research Group. Current status of emergency medical service use in ST-segment elevation myocardial infarction in China: Findings from China Acute Myocardial Infarction (CAMI) Registry. Int J Cardiol. 2024 Jul 1;406:132040. doi: 10.1016/j.ijcard.2024.132040. Epub 2024 Apr 16.

    PubMed 38614365

  • Jiang Y, Yang JG, Qian HY, Yang YJ. Association between living alone and all-cause mortality of young and middle-aged patients with acute myocardial infarction: analysis of the China Acute Myocardial Infarction (CAMI) registry. BMC Public Health. 2024 Jan 2;24(1):14. doi: 10.1186/s12889-023-17486-7.

    PubMed 38166780

  • Wu C, Gao X, Li L, Jing Q, Li W, Xu H, Zhang W, Li S, Zhao Y, Wang Y, Li W, Wu Y, Hu F, Jin C, Qiao S, Yang J, Yang Y; CAMI (China Acute Myocardial Infarction) Registry Study Group. Role of ST-Segment Resolution Alone and in Combination With TIMI Flow After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction. J Am Heart Assoc. 2023 Jul 18;12(14):e029670. doi: 10.1161/JAHA.123.029670. Epub 2023 Jul 14.

    PubMed 37449560

  • Cui K, Fu R, Yang J, Xu H, Yin D, Song W, Wang H, Zhu C, Feng L, Wang Z, Wang Q, Lu Y, Dou K, Yang Y; CAMI Registry Investigators. The impact of fasting stress hyperglycemia ratio, fasting plasma glucose and hemoglobin A1c on in-hospital mortality in patients with and without diabetes: findings from the China acute myocardial infarction registry. Cardiovasc Diabetol. 2023 Jul 4;22(1):165. doi: 10.1186/s12933-023-01868-7.

    PubMed 37403082

  • Lv J, Wang C, Gao X, Yang J, Zhang X, Ye Y, Dong Q, Fu R, Sun H, Yan X, Zhao Y, Wang Y, Xu H, Yang Y; China Acute Myocardial Infarction Registry study group. Development and validation of dynamic models to predict postdischarge mortality risk in patients with acute myocardial infarction: results from China Acute Myocardial Infarction Registry. BMJ Open. 2023 Mar 29;13(3):e069505. doi: 10.1136/bmjopen-2022-069505.

    PubMed 36990493

  • Zhao X, Wang J, Yang J, Chen T, Song Y, Li X, Xie G, Gao X, Xu H, Gao R, Yuan J, Yang Y. Machine learning for prediction of bleeding in acute myocardial infarction patients after percutaneous coronary intervention. Ther Adv Chronic Dis. 2023 Mar 4;14:20406223231158561. doi: 10.1177/20406223231158561. eCollection 2023.

    PubMed 36895330

  • Wu C, Li L, Wang S, Zeng J, Yang J, Xu H, Zhao Y, Wang Y, Li W, Jin C, Gao X, Yang Y, Qiao S. Fibrinolytic therapy use for ST-segment elevation myocardial infarction and long-term outcomes in China: 2-year results from the China Acute Myocardial Infarction Registry. BMC Cardiovasc Disord. 2023 Feb 22;23(1):103. doi: 10.1186/s12872-023-03105-1.

    PubMed 36814182

  • Fu R, Cui K, Yang J, Xu H, Yin D, Song W, Wang H, Zhu C, Feng L, Wang Z, Wang Q, Lu Y, Dou K, Yang Y; CAMI Registry Investigators. Fasting stress hyperglycemia ratio and in-hospital mortality after acute myocardial infarction in patients with different glucose metabolism status: Results from China acute myocardial infarction registry. Diabetes Res Clin Pract. 2023 Feb;196:110241. doi: 10.1016/j.diabres.2023.110241. Epub 2023 Jan 6.

    PubMed 36623641

  • Wei ZY, Yang JG, Qian HY, Yang YJ; China Acute Myocardial Infarction Registry Investigators. Impact of Marital Status on Management and Outcomes of Patients With Acute Myocardial Infarction: Insights From the China Acute Myocardial Infarction Registry. J Am Heart Assoc. 2022 Dec 6;11(23):e025671. doi: 10.1161/JAHA.122.025671. Epub 2022 Nov 29.

    PubMed 36444834

  • Cui K, Fu R, Yang J, Xu H, Yin D, Song W, Wang H, Zhu C, Feng L, Wang Z, Wang Q, Lu Y, Dou K, Yang Y. Admission Blood Glucose and 2-Year Mortality After Acute Myocardial Infarction in Patients With Different Glucose Metabolism Status: A Prospective, Nationwide, and Multicenter Registry. Front Endocrinol (Lausanne). 2022 Jun 15;13:898384. doi: 10.3389/fendo.2022.898384. eCollection 2022.

    PubMed 35784538

Questions about this trial

What is this clinical trial studying?

An observational study of Acute Myocardial Infarction, run by Chinese Academy of Medical Sciences, Fuwai Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 May 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

In-hospital mortality of the patients with acute myocardial infarction in different-level hospitals across China (time frame: the duration of hospital stay, an expected average of 2 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01874691, which also lists 25 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2022.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in